サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1788504

バイオテクノロジーの世界市場：産業分析、市場規模・シェア・成長・動向・予測 (2025～2035年)

Biotechnology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

出版日
ページ情報
英文 208 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.73円
バイオテクノロジーの世界市場：産業分析、市場規模・シェア・成長・動向・予測 (2025～2035年)
出版日: 2025年06月17日
発行: Transparency Market Research
ページ情報: 英文 208 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオテクノロジー市場 - 分析範囲

TMRの調査レポート「バイオテクノロジーの世界市場」は、2025～2035年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去および現在の成長動向と機会を調査しています。2025年を基準年、2035年を予測年として、2025～2035年までの世界のバイオテクノロジー市場の収益と予測を提供します。また、2025～2035年までの世界のバイオテクノロジー市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されました。一次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、バイオテクノロジー市場を推察しました。

市場スナップショット
市場規模（2024年） 1兆8,000億米ドル
市場規模（2035年） 5兆4,000億米ドル
CAGR 10.3%

当レポートでは、世界のバイオテクノロジー市場の競合情勢について調査しています。世界のバイオテクノロジー市場で事業を展開する主要企業が特定され、その各企業が様々な属性でプロファイルされています。会社概要、財務状況、最近の動向、SWOTは、本レポートで紹介した世界のバイオテクノロジー市場におけるプレイヤーの属性です。

世界のバイオテクノロジー市場レポートが回答した主な質問

  • 予測期間中の全地域におけるアフェレシスによる売上高／収益は？
  • 世界のバイオテクノロジー市場におけるビジネスチャンスは？
  • 市場の主な促進要因、市場抑制要因、機会、脅威は何か？
  • 予測期間中に最も速いCAGRで拡大する地域市場はどこか？
  • 2035年に世界で最も高い収益を上げると予測されるセグメントは？
  • 予測期間中に最も高いCAGRで拡大すると予測されるセグメントは？
  • 世界市場で事業を展開する各企業の市場ポジションは？

バイオテクノロジー市場 - 調査目的と調査手法

バイオテクノロジーの世界市場に関する包括的なレポートは、概要から始まり、調査範囲と目的が続きます。本調査の目的、市場で事業を展開する主要ベンダーや流通業者、製品承認に関する規制シナリオについて詳しく解説しています。

本レポートは、読みやすさを考慮し、各セクションを章ごとに分割したレイアウトになっています。本レポートは、グラフや表が適切に散りばめられた網羅的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化し、読者に視覚的に訴えます。また、過去と予測期間末の主要セグメントの市場シェアを比較することができます。

当レポートでは、世界のバイオテクノロジー市場を技術、用途、地域別に分析しています。各基準の主要セグメントを詳細に調査し、2035年末時点の各セグメントにおける市場シェアを掲載しています。このような貴重な洞察により、市場利害関係者は、世界のバイオテクノロジー市場への投資について、情報に基づいたビジネス上の意思決定を行うことができます。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー： 世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界のバイオテクノロジー市場分析と予測（2020～2035年）

第5章 主要洞察

  • 主要地域/国におけるヘルスケア費支出
  • 技術的進歩
  • 主要地域/国における規制シナリオ
  • ポーターのファイブフォース分析
  • PESTEL分析
  • バリューチェーン分析
  • エンドユーザーにとっての主要な購入指標
  • 新規市場参入者のための市場開拓戦略
  • 主要な業界イベント（パートナーシップ、コラボレーション、製品承認、合併および買収）
  • 主要競合が提供する主要技術のベンチマーク

第6章 世界の市場分析と予測：技術別

  • イントロダクション・定義
  • 主な分析結果/進展
  • 市場予測（金額ベース）：技術別（2020～2035年）
    • ポリメラーゼ連鎖反応（PCR）技術
    • 組織工学および再生
    • ナノバイオテクノロジー
    • クロマトグラフィー
    • DNAシーケンシング
    • 細胞ベースアッセイ
    • 発酵
    • バイオインフォマティクス
    • その他
  • 市場の魅力：技術別

第7章 世界の市場分析と予測：用途別

  • イントロダクション・定義
  • 主な分析結果/進展
  • 市場予測（金額ベース）：用途別（2020～2035年）
    • ヘルスケア
    • 農業
    • 食品・飲料
    • 産業バイオテクノロジー
    • 環境バイオテクノロジー
    • その他
  • 市場の魅力：用途別

第8章 世界の市場分析と予測：地域別

  • 主な分析結果
  • 市場予測（金額ベース）：：地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力：地域別

第9章 北米の市場分析と予測

  • 米国
  • カナダ

第10章 欧州の市場分析と予測

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • スイス
  • オランダ
  • その他欧州地域

第11章 アジア太平洋地域の市場分析と予測

  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリアとニュージーランド
  • その他アジア太平洋地域

第12章 ラテンアメリカの市場分析と予測

  • ブラジル
  • メキシコ
  • アルゼンチン
  • その他ラテンアメリカ地域

第13章 中東・アフリカの市場分析と予測

  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

第14章 競合情勢

  • 市場企業-競合マトリックス（企業階層別・規模別）
  • 市場シェア分析企業別（2024年）
  • 企業プロファイル
    • Abbott
    • AstraZeneca
    • Pfizer Inc.
    • F. Hoffmann-La Roche AG
    • Novartis AG
    • Merck & Co., Inc.
    • Eli Lilly and Company
    • Novo Nordisk A/S
    • Merck KGaA
    • Johnson & Johnson Services, Inc.
    • Amgen Inc.
    • GSK plc
    • Sanofi
    • Thermo Fisher Scientific Inc.
    • AbbVie Inc.
    • Bristol-Myers Squibb Company
    • Teva Pharmaceutical Industries Ltd.
    • Gilead Sciences, Inc.
    • Biogen Inc.
    • Moderna, Inc.
図表

List of Tables

  • Table 01: Global Biotechnology Market Value (US$ Tn) Forecast, By Technology, 2020 to 2035
  • Table 02: Global Biotechnology Market Value (US$ Tn) Forecast, By Application, 2020 to 2035
  • Table 03: Global Biotechnology Market Value (US$ Tn) Forecast, By Region, 2020 to 2035
  • Table 04: North America - Biotechnology Market Value (US$ Tn) Forecast, by Country, 2020 to 2035
  • Table 05: North America - Biotechnology Market Value (US$ Tn) Forecast, By Technology, 2020 to 2035
  • Table 06: North America - Biotechnology Market Value (US$ Tn) Forecast, By Application, 2020 to 2035
  • Table 07: Europe - Biotechnology Market Value (US$ Tn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 08: Europe - Biotechnology Market Value (US$ Tn) Forecast, By Technology, 2020 to 2035
  • Table 09: Europe - Biotechnology Market Value (US$ Tn) Forecast, By Application, 2020 to 2035
  • Table 10: Asia Pacific - Biotechnology Market Value (US$ Tn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 11: Asia Pacific - Biotechnology Market Value (US$ Tn) Forecast, By Technology, 2020 to 2035
  • Table 12: Asia Pacific - Biotechnology Market Value (US$ Tn) Forecast, By Application, 2020 to 2035
  • Table 13: Latin America - Biotechnology Market Value (US$ Tn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 14: Asia Pacific - Biotechnology Market Value (US$ Tn) Forecast, By Technology, 2020 to 2035
  • Table 15: Latin America - Biotechnology Market Value (US$ Tn) Forecast, By Application, 2020 to 2035
  • Table 16: Middle East & Africa - Biotechnology Market Value (US$ Tn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 17: Middle East & Africa - Biotechnology Market Value (US$ Tn) Forecast, By Technology, 2020 to 2035
  • Table 18: Middle East & Africa - Biotechnology Market Value (US$ Tn) Forecast, By Application, 2020 to 2035

List of Figures

  • Figure 01: Global Biotechnology Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 02: Global Biotechnology Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 03: Global Biotechnology Market Revenue (US$ Tn), by Polymerase Chain Reaction (PCR) Technology, 2020 to 2035
  • Figure 04: Global Biotechnology Market Revenue (US$ Tn), by Tissue Engineering and Regeneration, 2020 to 2035
  • Figure 05: Global Biotechnology Market Revenue (US$ Tn), by Nanobiotechnology, 2020 to 2035
  • Figure 06: Global Biotechnology Market Revenue (US$ Tn), by Chromatography, 2020 to 2035
  • Figure 07: Global Biotechnology Market Revenue (US$ Tn), by DNA Sequencing, 2020 to 2035
  • Figure 08: Global Biotechnology Market Revenue (US$ Tn), by Cell-based Assays, 2020 to 2035
  • Figure 09: Global Biotechnology Market Revenue (US$ Tn), by Fermentation, 2020 to 2035
  • Figure 10: Global Biotechnology Market Revenue (US$ Tn), by Bioinformatics, 2020 to 2035
  • Figure 11: Global Biotechnology Market Revenue (US$ Tn), by Others, 2020 to 2035
  • Figure 12: Global Biotechnology Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 13: Global Biotechnology Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 14: Global Biotechnology Market Revenue (US$ Tn), by Healthcare, 2020 to 2035
  • Figure 15: Global Biotechnology Market Revenue (US$ Tn), by Agriculture, 2020 to 2035
  • Figure 16: Global Biotechnology Market Revenue (US$ Tn), by Food & Beverages, 2020 to 2035
  • Figure 17: Global Biotechnology Market Revenue (US$ Tn), by Industrial Biotechnology, 2020 to 2035
  • Figure 18: Global Biotechnology Market Revenue (US$ Tn), by Environmental Biotechnology, 2020 to 2035
  • Figure 19: Global Biotechnology Market Revenue (US$ Tn), by Others, 2020 to 2035
  • Figure 20: Global Biotechnology Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 21: Global Biotechnology Market Attractiveness Analysis, By Region, 2025 to 2035
  • Figure 22: North America - Biotechnology Market Value (US$ Tn) Forecast, 2020 to 2035
  • Figure 23: North America - Biotechnology Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 24: North America - Biotechnology Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 25: North America - Biotechnology Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 26: North America - Biotechnology Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 27: North America - Biotechnology Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 28: North America - Biotechnology Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 29: Europe - Biotechnology Market Value (US$ Tn) Forecast, 2020 to 2035
  • Figure 30: Europe - Biotechnology Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 31: Europe - Biotechnology Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 32: Europe - Biotechnology Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 33: Europe - Biotechnology Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 34: Europe - Biotechnology Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 35: Europe - Biotechnology Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 36: Asia Pacific - Biotechnology Market Value (US$ Tn) Forecast, 2020 to 2035
  • Figure 37: Asia Pacific - Biotechnology Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 38: Asia Pacific - Biotechnology Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 39: Asia Pacific - Biotechnology Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 40: Asia Pacific - Biotechnology Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 41: Asia Pacific - Biotechnology Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 42: Asia Pacific - Biotechnology Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 43: Latin America - Biotechnology Market Value (US$ Tn) Forecast, 2020 to 2035
  • Figure 44: Latin America - Biotechnology Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 45: Latin America - Biotechnology Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 46: Latin America - Biotechnology Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 47: Latin America - Biotechnology Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 48: Latin America - Biotechnology Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 49: Latin America - Biotechnology Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 50: Middle East & Africa - Biotechnology Market Value (US$ Tn) Forecast, 2020 to 2035
  • Figure 51: Middle East & Africa - Biotechnology Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 52: Middle East & Africa - Biotechnology Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 53: Middle East & Africa - Biotechnology Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 54: Middle East & Africa - Biotechnology Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 55: Middle East & Africa - Biotechnology Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 56: Middle East & Africa - Biotechnology Market Attractiveness Analysis, By Application, 2025 to 2035
目次
Product Code: TMRGL86738

Biotechnology Market- Scope of Report

TMR's report on the global Biotechnology Marketstudies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global Biotechnology Marketfor the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Biotechnology Marketfrom 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the two-wheeler navigation display market.

Market Snapshot
Market Value in 2024US$ 1.8 Tn
Market Value in 2035US$ 5.4 Tn
CAGR10.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global two-wheeler navigation display market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global two-wheeler navigation display market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global two-wheeler navigation display market.

The report delves into the competitive landscape of the global two-wheeler navigation display market. Key players operating in the global Biotechnology Markethave been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Biotechnology Marketprofiled in this report.

Key Questions Answered in Global Biotechnology MarketReport:

  • What is the sales/revenue generated by apheresis across all regions during the forecast period?
  • What are the opportunities in the global two-wheeler navigation display market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Biotechnology Market- Research Objectives and Research Approach

The comprehensive report on the global Biotechnology Marketbegins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Biotechnology Marketin terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global two-wheeler navigation display market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Biotechnology Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Biotechnology Market Analysis and Forecasts, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Tn)

5. Key Insights

  • 5.1. Healthcare Expenditure across Key Regions / Countries
  • 5.2. Technological Advancements
  • 5.3. Regulatory Scenario across Key Regions / Countries
  • 5.4. PORTER's Five Forces Analysis
  • 5.5. PESTEL Analysis
  • 5.6. Value Chain Analysis
  • 5.7. Key Purchase Metrics for End-users
  • 5.8. Go-to-Market Strategy for New Market Entrants
  • 5.9. Key Industry Events (Partnerships, Collaborations, Product approvals, Mergers & acquisitions)
  • 5.10. Benchmarking of Key Technologies Offered by the Leading Competitors

6. Global Biotechnology Market Analysis and Forecasts, By Technology

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Technology, 2020 to 2035
    • 6.3.1. Polymerase Chain Reaction (PCR) Technology
    • 6.3.2. Tissue Engineering and Regeneration
    • 6.3.3. Nanobiotechnology
    • 6.3.4. Chromatography
    • 6.3.5. DNA Sequencing
    • 6.3.6. Cell-based Assays
    • 6.3.7. Fermentation
    • 6.3.8. Bioinformatics
    • 6.3.9. Others
  • 6.4. Market Attractiveness By Technology

7. Global Biotechnology Market Analysis and Forecasts, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2020 to 2035
    • 7.3.1. Healthcare
    • 7.3.2. Agriculture
    • 7.3.3. Food & Beverages
    • 7.3.4. Industrial Biotechnology
    • 7.3.5. Environmental Biotechnology
    • 7.3.6. Others
  • 7.4. Market Attractiveness By Application

8. Global Biotechnology Market Analysis and Forecasts, By Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast By Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness By Region

9. North America Biotechnology Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast By Technology, 2020 to 2035
    • 9.2.1. Polymerase Chain Reaction (PCR) Technology
    • 9.2.2. Tissue Engineering and Regeneration
    • 9.2.3. Nanobiotechnology
    • 9.2.4. Chromatography
    • 9.2.5. DNA Sequencing
    • 9.2.6. Cell-based Assays
    • 9.2.7. Fermentation
    • 9.2.8. Bioinformatics
    • 9.2.9. Others
  • 9.3. Market Value Forecast By Application, 2020 to 2035
    • 9.3.1. Healthcare
    • 9.3.2. Agriculture
    • 9.3.3. Food & Beverages
    • 9.3.4. Industrial Biotechnology
    • 9.3.5. Environmental Biotechnology
    • 9.3.6. Others
  • 9.4. Market Value Forecast By Country, 2020 to 2035
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Technology
    • 9.5.2. By Application
    • 9.5.3. By Country

10. Europe Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Technology, 2020 to 2035
    • 10.2.1. Polymerase Chain Reaction (PCR) Technology
    • 10.2.2. Tissue Engineering and Regeneration
    • 10.2.3. Nanobiotechnology
    • 10.2.4. Chromatography
    • 10.2.5. DNA Sequencing
    • 10.2.6. Cell-based Assays
    • 10.2.7. Fermentation
    • 10.2.8. Bioinformatics
    • 10.2.9. Others
  • 10.3. Market Value Forecast By Application, 2020 to 2035
    • 10.3.1. Healthcare
    • 10.3.2. Agriculture
    • 10.3.3. Food & Beverages
    • 10.3.4. Industrial Biotechnology
    • 10.3.5. Environmental Biotechnology
    • 10.3.6. Others
  • 10.4. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 10.4.1. Germany
    • 10.4.2. UK
    • 10.4.3. France
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Switzerland
    • 10.4.7. The Netherlands
    • 10.4.8. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Technology
    • 10.5.2. By Application
    • 10.5.3. By Country / Sub-region

11. Asia Pacific Biotechnology Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Technology, 2020 to 2035
    • 11.2.1. Polymerase Chain Reaction (PCR) Technology
    • 11.2.2. Tissue Engineering and Regeneration
    • 11.2.3. Nanobiotechnology
    • 11.2.4. Chromatography
    • 11.2.5. DNA Sequencing
    • 11.2.6. Cell-based Assays
    • 11.2.7. Fermentation
    • 11.2.8. Bioinformatics
    • 11.2.9. Others
  • 11.3. Market Value Forecast By Application, 2020 to 2035
    • 11.3.1. Healthcare
    • 11.3.2. Agriculture
    • 11.3.3. Food & Beverages
    • 11.3.4. Industrial Biotechnology
    • 11.3.5. Environmental Biotechnology
    • 11.3.6. Others
  • 11.4. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 11.4.1. China
    • 11.4.2. India
    • 11.4.3. Japan
    • 11.4.4. South Korea
    • 11.4.5. Australia & New Zealand
    • 11.4.6. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Technology
    • 11.5.2. By Application
    • 11.5.3. By Country / Sub-region

12. Latin America Biotechnology Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Technology, 2020 to 2035
    • 12.2.1. Polymerase Chain Reaction (PCR) Technology
    • 12.2.2. Tissue Engineering and Regeneration
    • 12.2.3. Nanobiotechnology
    • 12.2.4. Chromatography
    • 12.2.5. DNA Sequencing
    • 12.2.6. Cell-based Assays
    • 12.2.7. Fermentation
    • 12.2.8. Bioinformatics
    • 12.2.9. Others
  • 12.3. Market Value Forecast By Application, 2020 to 2035
    • 12.3.1. Healthcare
    • 12.3.2. Agriculture
    • 12.3.3. Food & Beverages
    • 12.3.4. Industrial Biotechnology
    • 12.3.5. Environmental Biotechnology
    • 12.3.6. Others
  • 12.4. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Argentina
    • 12.4.4. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Technology
    • 12.5.2. By Application
    • 12.5.3. By Country / Sub-region

13. Middle East & Africa Biotechnology Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Technology, 2020 to 2035
    • 13.2.1. Polymerase Chain Reaction (PCR) Technology
    • 13.2.2. Tissue Engineering and Regeneration
    • 13.2.3. Nanobiotechnology
    • 13.2.4. Chromatography
    • 13.2.5. DNA Sequencing
    • 13.2.6. Cell-based Assays
    • 13.2.7. Fermentation
    • 13.2.8. Bioinformatics
    • 13.2.9. Others
  • 13.3. Market Value Forecast By Application, 2020 to 2035
    • 13.3.1. Healthcare
    • 13.3.2. Agriculture
    • 13.3.3. Food & Beverages
    • 13.3.4. Industrial Biotechnology
    • 13.3.5. Environmental Biotechnology
    • 13.3.6. Others
  • 13.4. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Technology
    • 13.5.2. By Application
    • 13.5.3. By Country / Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 14.2. Market Share Analysis By Company (2024)
  • 14.3. Company Profiles
    • 14.3.1. Abbott
      • 14.3.1.1. Company Overview
      • 14.3.1.2. Financial Overview
      • 14.3.1.3. Product Portfolio
      • 14.3.1.4. Business Strategies
      • 14.3.1.5. Recent Developments
    • 14.3.2. AstraZeneca
      • 14.3.2.1. Company Overview
      • 14.3.2.2. Financial Overview
      • 14.3.2.3. Product Portfolio
      • 14.3.2.4. Business Strategies
      • 14.3.2.5. Recent Developments
    • 14.3.3. Pfizer Inc.
      • 14.3.3.1. Company Overview
      • 14.3.3.2. Financial Overview
      • 14.3.3.3. Product Portfolio
      • 14.3.3.4. Business Strategies
      • 14.3.3.5. Recent Developments
    • 14.3.4. F. Hoffmann-La Roche AG
      • 14.3.4.1. Company Overview
      • 14.3.4.2. Financial Overview
      • 14.3.4.3. Product Portfolio
      • 14.3.4.4. Business Strategies
      • 14.3.4.5. Recent Developments
    • 14.3.5. Novartis AG
      • 14.3.5.1. Company Overview
      • 14.3.5.2. Financial Overview
      • 14.3.5.3. Product Portfolio
      • 14.3.5.4. Business Strategies
      • 14.3.5.5. Recent Developments
    • 14.3.6. Merck & Co., Inc.
      • 14.3.6.1. Company Overview
      • 14.3.6.2. Financial Overview
      • 14.3.6.3. Product Portfolio
      • 14.3.6.4. Business Strategies
      • 14.3.6.5. Recent Developments
    • 14.3.7. Eli Lilly and Company
      • 14.3.7.1. Company Overview
      • 14.3.7.2. Financial Overview
      • 14.3.7.3. Product Portfolio
      • 14.3.7.4. Business Strategies
      • 14.3.7.5. Recent Developments
    • 14.3.8. Novo Nordisk A/S
      • 14.3.8.1. Company Overview
      • 14.3.8.2. Financial Overview
      • 14.3.8.3. Product Portfolio
      • 14.3.8.4. Business Strategies
      • 14.3.8.5. Recent Developments
    • 14.3.9. Merck KGaA
      • 14.3.9.1. Company Overview
      • 14.3.9.2. Financial Overview
      • 14.3.9.3. Product Portfolio
      • 14.3.9.4. Business Strategies
      • 14.3.9.5. Recent Developments
    • 14.3.10. Johnson & Johnson Services, Inc.
      • 14.3.10.1. Company Overview
      • 14.3.10.2. Financial Overview
      • 14.3.10.3. Product Portfolio
      • 14.3.10.4. Business Strategies
      • 14.3.10.5. Recent Developments
    • 14.3.11. Amgen Inc.
      • 14.3.11.1. Company Overview
      • 14.3.11.2. Financial Overview
      • 14.3.11.3. Product Portfolio
      • 14.3.11.4. Business Strategies
      • 14.3.11.5. Recent Developments
    • 14.3.12. GSK plc
      • 14.3.12.1. Company Overview
      • 14.3.12.2. Financial Overview
      • 14.3.12.3. Product Portfolio
      • 14.3.12.4. Business Strategies
      • 14.3.12.5. Recent Developments
    • 14.3.13. Sanofi
      • 14.3.13.1. Company Overview
      • 14.3.13.2. Financial Overview
      • 14.3.13.3. Product Portfolio
      • 14.3.13.4. Business Strategies
      • 14.3.13.5. Recent Developments
    • 14.3.14. Thermo Fisher Scientific Inc.
      • 14.3.14.1. Company Overview
      • 14.3.14.2. Financial Overview
      • 14.3.14.3. Product Portfolio
      • 14.3.14.4. Business Strategies
      • 14.3.14.5. Recent Developments
    • 14.3.15. AbbVie Inc.
      • 14.3.15.1. Company Overview
      • 14.3.15.2. Financial Overview
      • 14.3.15.3. Product Portfolio
      • 14.3.15.4. Business Strategies
      • 14.3.15.5. Recent Developments
    • 14.3.16. Bristol-Myers Squibb Company
      • 14.3.16.1. Company Overview
      • 14.3.16.2. Financial Overview
      • 14.3.16.3. Product Portfolio
      • 14.3.16.4. Business Strategies
      • 14.3.16.5. Recent Developments
    • 14.3.17. Teva Pharmaceutical Industries Ltd.
      • 14.3.17.1. Company Overview
      • 14.3.17.2. Financial Overview
      • 14.3.17.3. Product Portfolio
      • 14.3.17.4. Business Strategies
      • 14.3.17.5. Recent Developments
    • 14.3.18. Gilead Sciences, Inc.
      • 14.3.18.1. Company Overview
      • 14.3.18.2. Financial Overview
      • 14.3.18.3. Product Portfolio
      • 14.3.18.4. Business Strategies
      • 14.3.18.5. Recent Developments
    • 14.3.19. Biogen Inc.
      • 14.3.19.1. Company Overview
      • 14.3.19.2. Financial Overview
      • 14.3.19.3. Product Portfolio
      • 14.3.19.4. Business Strategies
      • 14.3.19.5. Recent Developments
    • 14.3.20. Moderna, Inc.
      • 14.3.20.1. Company Overview
      • 14.3.20.2. Financial Overview
      • 14.3.20.3. Product Portfolio
      • 14.3.20.4. Business Strategies
      • 14.3.20.5. Recent Developments